To our knowledge, the role of pre-cDC1s in alloreactivity and GvHD, and in generating anti-tumor responses, has not been previously investigated, despite studies documenting their superior ability to cross-prime CD8+ T-cells compared to mature CD8α+ cDC1s [5, 10]. This evidence concerns the gene CD8A and neoplasm.